A landmark study published in Diabetologia has quantified the direct impact of magnesium deficiency on cellular insulin response. Researchers demonstrated that magnesium depletion reduces insulin receptor activation by 50%, a finding that provides mechanistic explanation for the epidemiological association between low magnesium and insulin resistance.
The key insight: this impairment occurs at the level of receptor phosphorylation, the internal signaling process that enables glucose uptake. Insulin binding and glucose transporters remain intact, yet the critical signaling cascade fails. This distinction is clinically important because it identifies a specific, addressable metabolic bottleneck. Supporting these cellular findings, meta-analyses of over 1.5 million participants show consistent 14-19% reductions in type 2 diabetes risk associated with higher magnesium intake, suggesting that maintaining adequate magnesium status may be a modifiable factor in diabetes prevention.
Read the full article on GMJ Newsroom.
Was this article helpful?
